Japanese cancer and oncology medicines.

What are Japanese oncology medicines' features?

In Japan, oncology is the top reason of death among population. Stomach and lung cancer have become the main causes of death in the Land of the Rising Sun long ago. In this regard, many preventive medicines have been developed in Japan, as well as medicines that effectively fight cancer that has already developed and malignant tumors. These medicines have different functions. Some carry out prevention, cleansing the body of toxins and eliminating the conditions in which malignant cells can form and regenerate. The others kill or make reproduction of already formed cancer cells and tumors impossible. Let’s check these types in details.

What types of Japanese oncology medicines are divided into?

By type, Japanese cancer medicines can be divided into the following groups.

• The first is biologically active agents that inhibit growth and reduce the possibility of the formation of tumors. These include famous fucoidan, resveratrol, chitosan from shiitake etc.
• The second group includes classical medicines for chemical therapy - for the treatment of lung cancer, such as TS-1 and Amrubicin.
• The third group, which appeared quite recently, can be attributed to medicines of immunotherapy, such as Obdivo, for which the Nobel Prize in Medicine was awarded in 2018.

What is the mechanism of action of Japanese cancer and oncology medicines?

The mechanism of action of Japanese cancer medicines and various types of oncology depends on the group to which the medicine belongs to. The first group creates an uncomfortable environment in the body for the growth and development of degenerated cells. Apaptosis (dying) of mutated cells is fixed primarily at high doses of fucoidan, resveratrol and chitosan from Japanese shiitake mushrooms. The second group acts in an excellent way, either by inhibiting the growth of cancer cells, or by acting on them at the molecular level. The third group of innovative immune therapy for Japanese cancer medicines, which includes Obdivo, reprograms the immune system, forcing the tumor to be perceived as a foreign body, requiring attack and removal. Usually, cancer cells "cheat" the immune system, so cope with cancer can be so difficult.

Japanese oncology medicines: are they effective?

With all the abundance of development, Japan, like other countries, is far from defeating cancer. A 100% effective medicine for oncology, unfortunately, still does not exist. While the mechanisms of rebirth are not clear, you can spend tens and hundreds of thousands of dollars on the latest treatment, but cancer can always return. On the other hand, if you lead a healthy lifestyle and take preventive measures in a timely manner, the probability of developing the disease is significantly reduced. Plus, with regular clinical examination it is possible to identify the disease at an early stage. In this case, the chances of defeating cancer are close to 100%, because medicine does not stand still, and every year there are more and more new medicines to combat this terrible disease.

How to choose the right medicine for cancer treatment?

Here you can only advise one thing - contact your doctor. Of course, medicines like fucoidan will not harm and will only bring benefit at any stage of the disease, but to declare that they will help would be unfair. For the treatment of serious diseases requires a serious approach. Of course, if you have a benign education or you are just afraid and want to take preventive courses, we can recommend trying fucoidan, turmeric extract or resveratrol. However, a serious illness requires serious diagnostics and a fundamental integrated approach to treatment. Contact the specialists and they will help you, provide advice on your specific case.

Is there an effective medicine for cancer and oncology in Japan?

Unfortunately, there is nowhere an unequivocally and absolutely effective cure for cancer. However, there are good prophylactic medicines with proven effects, as well as specialized medicines for the treatment of certain forms of cancer with a specific diagnosis. It is important to remember that early diagnosis dramatically increases the patient’s chances for recovery. Medicines like fucoidan in their maximum dosage give effective results. However, with progressive tumors, their effectiveness does not exceed 20%. In such cases, it is recommended to refer to the medicines of class TC-1 and Amrubicin, which have a proven and serious effect in the treatment of oncology.